These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


71 related items for PubMed ID: 8531249

  • 1. Cytotoxic therapy and side effect in childhood.
    Inaba S.
    J Toxicol Sci; 1995 Sep; 20(4):485-6. PubMed ID: 8531249
    [No Abstract] [Full Text] [Related]

  • 2. [Body height increase and secretion of somatotropin in children with variously treated hephrotic syndromes].
    Cicognani A, Mei V, Pirazzoli P, Tassoni P, Collina A, Tazzari R, Cacciari E.
    Minerva Pediatr; 1973 Apr 14; 25(13):583-92. PubMed ID: 4350774
    [No Abstract] [Full Text] [Related]

  • 3. Linear growth and final height in patients with systemic juvenile idiopathic arthritis treated with longterm glucocorticoids.
    Simon D, Fernando C, Czernichow P, Prieur AM.
    J Rheumatol; 2002 Jun 14; 29(6):1296-300. PubMed ID: 12064849
    [Abstract] [Full Text] [Related]

  • 4. Remarkable catch-up growth in a boy with steroid-responsive nephrotic syndrome.
    Steendijk R.
    Acta Endocrinol Suppl (Copenh); 1986 Jun 14; 279():8-12. PubMed ID: 3465181
    [Abstract] [Full Text] [Related]

  • 5. In steroid sensitive nephrotic syndrome (SSNS) in children, is there clear evidence that steroids given every second day are more beneficial in terms of reducing relapse rate and side effects compared with half the dose given every day?
    Hodson EM, Craig JC.
    Pediatr Nephrol; 2001 Dec 14; 16(12):1159-60. PubMed ID: 11793121
    [No Abstract] [Full Text] [Related]

  • 6. [Results of treatment of nephrosis in childhood over a period of 16 years].
    Reimold EW, Wortmann D, Jungblut R.
    Med Welt; 1969 Sep 20; 64(38):2055-60. PubMed ID: 4187953
    [No Abstract] [Full Text] [Related]

  • 7. Follow-up of linear growth of body height in children with nephrotic syndrome.
    Hung YT, Yang LY.
    J Microbiol Immunol Infect; 2006 Oct 20; 39(5):422-5. PubMed ID: 17066206
    [Abstract] [Full Text] [Related]

  • 8. Chlorambucil in steroid-dependent nephrotic syndrome.
    Grupe WE.
    J Pediatr; 1973 Apr 20; 82(4):598-606. PubMed ID: 4121460
    [No Abstract] [Full Text] [Related]

  • 9. Current management of the nephrotic syndrome in childhood with emphasis on the role of cyclophosphamide.
    Kelsch RC, Oliver WJ.
    Mich Med; 1972 Dec 20; 71(35):999-1003. PubMed ID: 4636891
    [No Abstract] [Full Text] [Related]

  • 10. Treatment of childhood nephrotic syndrome with Imuran.
    Alatas H, Wirja IG, Sutedjo.
    Paediatr Indones; 1972 Sep 20; 12(9):363-71. PubMed ID: 4679474
    [No Abstract] [Full Text] [Related]

  • 11. Growth in children with chronic lung disease.
    Davis PB, Kercsmar CM.
    N Engl J Med; 2000 Mar 23; 342(12):887-8. PubMed ID: 10727595
    [No Abstract] [Full Text] [Related]

  • 12. Linear growth of low-dose cyclosporin A therapy in children with steroid-dependent nephrotic syndrome.
    Kano K, Nishikura K, Hoshi M, Yamada Y, Arisaka O.
    Nephron; 2001 Mar 23; 87(3):293-4. PubMed ID: 11287771
    [No Abstract] [Full Text] [Related]

  • 13. [Therapy and therapeutic results of the nephrotic syndrome in childhood].
    Rosenkranz A.
    Wien Z Inn Med; 1969 Mar 23; 50(5):205-9. PubMed ID: 5362187
    [No Abstract] [Full Text] [Related]

  • 14. Growth and glucocorticoids in children with kidney disease.
    Travis LB, Chesney R, McEnery P, Moel D, Pennisi A, Potter D, Talwalkar YB, Wolff E.
    Kidney Int; 1978 Oct 23; 14(4):365-8. PubMed ID: 366232
    [Abstract] [Full Text] [Related]

  • 15. [Therapeutic approaches of nephrotic syndrome in children at the beginning of the XXI century].
    Simón J, Zamora I.
    Nefrologia; 2003 Oct 23; 23(4):287-90. PubMed ID: 14558325
    [No Abstract] [Full Text] [Related]

  • 16. [Seconardy early cataract and corticotherapy].
    Antillón F, Pineda JL.
    Bol Med Hosp Infant Mex; 1975 Oct 23; 32(1):121-4. PubMed ID: 1109281
    [No Abstract] [Full Text] [Related]

  • 17. High dose, alternate day corticosteroids for systemic onset juvenile rheumatoid arthritis.
    Kimura Y, Fieldston E, Devries-Vandervlugt B, Li S, Imundo L.
    J Rheumatol; 2000 Aug 23; 27(8):2018-24. PubMed ID: 10955346
    [Abstract] [Full Text] [Related]

  • 18. Initial treatment of idiopathic nephrotic syndrome in children: prednisone versus prednisone plus cyclosporine A: a prospective, randomized trial.
    Hoyer PF, Brodeh J.
    J Am Soc Nephrol; 2006 Apr 23; 17(4):1151-7. PubMed ID: 16540560
    [Abstract] [Full Text] [Related]

  • 19. Growth in steroid-responsive nephrotic syndrome: a study of 85 pediatric patients.
    Donatti TL, Koch VH, Fujimura MD, Okay Y.
    Pediatr Nephrol; 2003 Aug 23; 18(8):789-95. PubMed ID: 12750984
    [Abstract] [Full Text] [Related]

  • 20. [Contribution to gluocorticoid therapy of the nephrotic syndrome].
    Hennighausen H, Osten B, Kröger E.
    Z Gesamte Inn Med; 1968 Dec 15; 23(24):816-9. PubMed ID: 5710622
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 4.